Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus

Neurology

Volumn 83, Issue 17, 2014, Pages 1573-1575

  Graff Radford, Neill R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID DRAINAGE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL FLUID; MAJOR CLINICAL STUDY; MALE; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL; SHUNTING; HYDROCEPHALUS, NORMAL PRESSURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84925553630     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000916     Document Type: Article

References (8)

1. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373-377.
2. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003;2:605-613.
3. Agren-Wilsson A, Lekman A, Sjoberg W, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 2007;116:333-339.
4. Kapaki EN, Paraskevas GP, Tzerakis NG, et al. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur J Neurol 2007;14:168-173.
5. Jeppsson A, Zetterberg H, Blennow K, Wikkelso C. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology 2013;80: 1385-1392.
6. Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir 2012;52:775-809.
7. Klinge P, Berding G, Brinker T, Weckesser E, Knapp WH, Samii M. Regional cerebral blood flow profiles of shunt-responder in idiopathic chronic hydrocephalus: a 15-O-water PET-study. Acta Neurochir Suppl 2002;81:47-49.
8. Vanderstichele H, Bibl M, Engelborghs S, et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 2012;8: 65-73.